Viviana Moroso, Ph.D.

QC and Medical Writer

Bio

  • Joined Pharmetheus in 2020, actively working in client projects, with continuous improvements, and providing medical writing support
  • Expertise includes medical writing and quality control across therapeutic areas
  • Previously worked as freelance Medical Writer and Editor where she prepared publications, conference presentations, medical communications, copyediting for publishers, and provided workshops on academic English writing, and as Laboratory Technician at Unilabs Pathology, Sweden
  • M.Sc. in Medical Biotechnology (2008) from the University of Trieste, Italy, and Ph.D. in Clinical and Basic Immunology (2011) from the Erasmus Medical Center, Rotterdam, the Netherlands
LinkedInGoogle Scholar

Pharmetheus affiliated publications

Bimekizumab population pharmacokinetic and exposure-response analyses in adults with moderate to severe hidradenitis suppurativaFull random effects models (FREM): A practical usage guideProperties of the full random-effect modeling approach with missing covariate dataEfficient and relevant stepwise covariate model building for pharmacometrics [2]Rituximab PK and PD evaluation based on a study in diffuse large B-cell lymphoma: influence of tumor size on PK and assessment of PK similarityWriting reports of modelling and simulation analysis: Our experience in the field of pharmacometricsEfficient and relevant stepwise covariate model building for pharmacometrics [1]Rituximab pharmacokinetic and pharmacokinetic–pharmacodynamic evaluation based on a study in diffuse large B-cell lymphoma: Influence of tumor size on pharmacokinetic and assessment of pharmacokinetic similarityCaplacizumab Model-Based Dosing Recommendations in Pediatric Patients With Acquired Thrombotic Thrombocytopenic Purpura [2]